share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
SEC announcement ·  03/19 16:41
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 20,054 Class A shares on 03/19/2024, as per the latest filing. These shares, initially acquired on 09/01/2016 as founders shares, were part of Borgeson's compensation from the issuer. The sale is expected to yield an aggregate market value of approximately $216,423. Borgeson's transaction history over the past three months includes the sale of 111,717 shares, generating total gross proceeds of around $1,293,849. The upcoming sale follows a series of transactions by Borgeson, with the most recent sale occurring on 03/05/2024.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 20,054 Class A shares on 03/19/2024, as per the latest filing. These shares, initially acquired on 09/01/2016 as founders shares, were part of Borgeson's compensation from the issuer. The sale is expected to yield an aggregate market value of approximately $216,423. Borgeson's transaction history over the past three months includes the sale of 111,717 shares, generating total gross proceeds of around $1,293,849. The upcoming sale follows a series of transactions by Borgeson, with the most recent sale occurring on 03/05/2024.
根据最新文件,Recursion Pharmicals, Inc.董事布莱克·博格森定于2024年3月19日出售20,054股A类股票。这些股票最初于2016年1月9日作为创始人股票收购,是博格森从发行人那里获得的薪酬的一部分。此次出售预计将产生约216,423美元的总市值。博格森在过去三个月中的交易记录包括出售111,717股股票,总收益约为1,293,849美元。即将进行的出售是在博格森进行了一系列交易之后进行的,最近的出售发生在2024年5月3日。
根据最新文件,Recursion Pharmicals, Inc.董事布莱克·博格森定于2024年3月19日出售20,054股A类股票。这些股票最初于2016年1月9日作为创始人股票收购,是博格森从发行人那里获得的薪酬的一部分。此次出售预计将产生约216,423美元的总市值。博格森在过去三个月中的交易记录包括出售111,717股股票,总收益约为1,293,849美元。即将进行的出售是在博格森进行了一系列交易之后进行的,最近的出售发生在2024年5月3日。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息